Antidepressants in oncology: Issues and clinical perspectives;Les antidépresseurs: Enjeux et perspectives cliniques en cancérologie

Bulletin du Cancer

Volumn 95, Issue 11, 2008, Pages 1103-1111

  Barrière, Jérôme ^a   Cherikh, Faredj ^b   Pringuey, Dominique ^b   Milano, Gérard ^a   Ferrero, Jean Marc ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Antidepressants; Cancer; Depression; Hot flashes; Pain; Supportive care

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DOCETAXEL; DULOXETINE; EFFEXOR LP; ESCITALOPRAM; ETOPOSIDE; FLUOXETINE; GEFITINIB; IFOSFAMIDE; IMATINIB; METOPROLOL; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; NAVELBINE; NORSET; PACLITAXEL; PAROXETINE; SEROPLEX; SERTRALINE; TAMOXIFEN; THALIDOMIDE; TIANEPTINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VINBLASTINE; VINCRISTINE;

CANCER PATIENT; DEPRESSION; DRUG CONTRAINDICATION; DRUG EFFICACY; HOT FLUSH; HUMAN; MEDICAL PRACTICE; NEOPLASM; PAIN; PATIENT CARE; REVIEW;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FATIGUE; HOT FLASHES; HUMANS; NEOPLASMS; PAIN;

EID: 58049175299     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0736     Document Type: Review

References (55)

1. Agence française de sécurité sanitaire des produits de santé. Bon usage des médicaments antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte. Afssaps : octobre 2006.
2. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998 ; 16(4) : 1594-600.
3. Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, et al. Major depression in outpatients attending a regional cancer centre : screening and unmet treatment needs. Br J Cancer 2004 ; 90 : 314-20.
4. Chochinov HM. Depression in cancer patients. Lancet Oncol 2001 ; 2 : 499-505.
5. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004 ; 32 : 57-71.
6. Pasquini M, Biondi M. Depression in cancer patients : a critical review. Clin Pract Epidemol Ment Health 2007 ; 3 : 2.
7. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer : five year observational cohort study. BMJ 2005 ; 26(330) : 702.
8. Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer : a comparative analysis. Aust N Z J Psychiatry 2004 ; 38 : 320-6.
9. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004 ; 32 : 80-92.
10. Endicott J. Measurement of depression in patients with cancer. Cancer 1984 ; 53 : 2243-9.
11. Aapro M, Cull A. Depression in breast cancer patients : the need for treatment. Ann Oncol 1999 ; 10 : 627-36.
12. Prieto JM, Atala J, Blanch J, et al. The role of depression as a predictor of mortality among cancer patients after stem cell transplantation. J Clin Oncol 2005 ; 23 : 6063-71.
13. Steel JL, Geller DA, Gamblin TC, et al. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 2007 ; 25 : 2397-405.
14. Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat 2007 ; 105 : 209-19.
15. Dormer NR, McCaul KA, Kristjanson LJ. Risk of suicide in cancer patients in Western Australia, 1981-2002. Med J Aust 2008 ; 188 : 140-3.
16. Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000 ; 356 : 1326-7.
17. Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomized clinical trials. Br J Psychiatry 1999 ; 174 : 297-303.
18. Thase ME, Fava M, Zimmerman M, Culpepper L. Review of the pharmacologic management of depression. J Clin Psychiatry 2006 ; 67 : 478-89.
19. Ronson A. Neurotrophic theories of stress and neurobiology of antidepressants : applications in psycho-oncology. Bull Cancer 2007 ; 94 : 431-8.
20. Paykel ES. Continuation and maintenance therapy in depression. Br Med Bull 2001 ; 57 : 145-59.
21. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression : a systematic review. Arch Gen Psychiatry 2004 ; 61 : 714-9.
22. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease : the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007 ; 297 : 367-79.
23. Fisch MJ. Treatment of depression in cancer. J Natl Cancer Inst Monogr 2004 ; 32 : 105-11.
24. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer : a systematic review. Br J Cancer 2006 ; 94 : 372-90.
25. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2005 ; 89 : 243-9.
26. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer : a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 2001 ; 70 : 1-10.
27. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001 ; 344 : 961-6.
28. Razavi D, Allilaire JF, Smith M, Salimpour A, Verra M, Desclaux B, et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996 ; 94 : 205-10.
29. Fisch MJ, Loehrer PJ, Kristeller J, Passik S, Jung SH, Shen J, et al. Fluoxetine versus placebo in advanced cancer outpatients : a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003 ; 21 : 1937-43.
30. Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, et al. Zoloft's Effects on Symptoms and survival Time Trial Group. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression : a placebo-controlled double-blind randomised trial. Lancet Oncol 2007 ; 8 : 603-12.
31. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2007 ; [Epub ahead of print].
32. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain : a meta-analysis of 39 placebo-controlled studies. Pain 1992 ; 49 : 205-19.
33. Delgado PL. Common pathways of depression and pain. J Clin Psychiatry 2004 ; 65 : 16-9.
34. Walsh TD. Controlled study of imipramine and morphine in chronic pain due to advanced cancer. Proc Am Soc Clin Oncol 1986 ; 5 : 237.
35. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004 ; 9 : 571-91.
36. Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996 ; 64 : 293-302.
37. McCleane G. Antidepressants as analgesics. CNS Drugs 2008 ; 22 : 139-56.
38. Attal N. Drug treatment for neuropathic pain. Presse Med 2008 ; 37 : 346-53.
39. Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 2002 ; 6 : 17-24.
40. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001 ; 57 : 1583-8.
41. Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, et al. Non-hormonal therapies for menopausal hot flashes : systematic review and meta-analysis. JAMA 2006 ; 295 : 2057-71.
42. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer : a randomised controlled trial. Lancet 2000 ; 356 : 2059-63.
43. Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, et al. Paroxetine is an effective treatment for hot flashes : results from a prospective randomized clinical trial. J Clin Oncol 2005 ; 23 : 6919-30.
44. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002 ; 20 : 1578-83.
45. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004 ; 32 : 40-50.
46. Breitbart W, Alici-Evcimen Y. Update on psychotropic medications for cancer-related fatigue. J Natl Compr Canc Netw 2007 ; 5 : 1081-91.
47. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PLR, Flynn PJ, et al. Differential effects of paroxetine on fatigue and depression : a randomized double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Program. J Clin Oncol 2003 ; 21 : 4635-41.
48. DeVane CL. Antidepressant-drug interactions are potentially but rarely clinically significant. Neuropsychopharmacology 2006 ; 31 : 1594-604.
49. Mathijssen RH, van Schaik RH. Genotyping and phenotyping cytochrome P450 : perspectives for cancer treatment. Eur J Cancer 2006 ; 42 : 141-8.
50. Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005 ; 97 : 30-9.
51. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007 ; 101 : 113-21.
52. Steingart A, Cotterchio M, Kreiger N, Sloan M. Antidepressant medication use and breast cancer risk : a case-control study. Int J Epidemiol 2003 ; 32 : 961-6.
53. Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 2007 ; [Epub ahead of print].
54. Xu W, Tamim H, Shapiro S, Stang MR, Collet JP. Use of antidepressants and risk of colorectal cancer : a nested case-control study. Lancet Oncol 2006 ; 7 : 301-8.
55. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004 ; 164 : 2367-70.